Takeda Pharmaceutical (TAK) reported fiscal Q1 core earnings Thursday of 154 Japanese yen ($0.94) per share, up from 151 yen a year earlier.
Four analysts polled by FactSet expected 143.97 yen.
Revenue for the quarter ended June 30 was 1.220 trillion, compared with 1.107 trillion yen a year earlier.
Analysts expected 1.150 trillion yen.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments